Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-16-126786

Director acquired 130,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SCHAFFER DERACE L · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-30 Exercise or conversion : show line 1 in the form +10,000 $2.59 $25,900 903,782 D
2016-09-30 Exercise or conversion : show line 2 in the form +20,000 $2.47 $49,400 923,782 D
2016-09-30 Exercise or conversion : show line 3 in the form +20,000 $1.60 $32,000 943,782 D
2016-09-30 Exercise or conversion : show line 4 in the form +20,000 $1.45 $29,000 963,782 D
2016-09-30 Exercise or conversion : show line 5 in the form +20,000 $1.64 $32,800 983,782 D
2016-09-30 Exercise or conversion : show line 6 in the form +20,000 $1.51 $30,200 1,003,782 D
2016-09-30 Exercise or conversion : show line 7 in the form +20,000 $1.69 $33,800 1,023,782 D

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2016-09-30 Exercise or conversion : show line 8 in the form Stock option (right to buy) −10,000 0 D
2016-09-30 Exercise or conversion : show line 9 in the form Stock option (right to buy) −20,000 0 D
2016-09-30 Exercise or conversion : show line 10 in the form Stock option (right to buy) −20,000 0 D
2016-09-30 Exercise or conversion : show line 11 in the form Stock option (right to buy) −20,000 0 D
2016-09-30 Exercise or conversion : show line 12 in the form Stock option (right to buy) −20,000 0 D
2016-09-30 Exercise or conversion : show line 13 in the form Stock option (right to buy) −20,000 0 D
2016-09-30 Exercise or conversion : show line 14 in the form Stock option (right to buy) −20,000 0 D
Loading xslF345X03/v450001_4.xml…